annual FCF:
-$40.56M-$9.15M(-29.12%)Summary
- As of today (September 17, 2025), TGTX annual free cash flow is -$40.56 million, with the most recent change of -$9.15 million (-29.12%) on December 31, 2024.
- During the last 3 years, TGTX annual FCF has risen by +$255.47 million (+86.30%).
- TGTX annual FCF is now -46738.34% below its all-time high of -$86.60 thousand, reached on December 31, 2011.
Performance
TGTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$7.39M+$36.13M(+125.73%)Summary
- As of today (September 17, 2025), TGTX quarterly free cash flow is $7.39 million, with the most recent change of +$36.13 million (+125.73%) on June 30, 2025.
- Over the past year, TGTX quarterly FCF has increased by +$1.86 million (+33.56%).
- TGTX quarterly FCF is now -91.17% below its all-time high of $83.70 million, reached on September 30, 2023.
Performance
TGTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$59.24M+$1.86M(+3.04%)Summary
- As of today (September 17, 2025), TGTX TTM free cash flow is -$59.24 million, with the most recent change of +$1.86 million (+3.04%) on June 30, 2025.
- Over the past year, TGTX TTM FCF has dropped by -$127.06 million (-187.34%).
- TGTX TTM FCF is now -187.34% below its all-time high of $67.82 million, reached on June 30, 2024.
Performance
TGTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TGTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.1% | +33.6% | -187.3% |
| 3 y3 years | +86.3% | +115.0% | +78.2% |
| 5 y5 years | +69.5% | +116.8% | +65.1% |
TGTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.1% | +86.3% | -91.2% | +112.3% | -187.3% | +78.2% |
| 5 y | 5-year | -29.1% | +86.3% | -91.2% | +108.5% | -187.3% | +80.0% |
| alltime | all time | <-9999.0% | +86.3% | -91.2% | +108.5% | -187.3% | +80.0% |
TGTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $7.39M(-125.7%) | -$59.24M(-3.0%) |
| Mar 2025 | - | -$28.74M(+12.0%) | -$61.09M(+50.6%) |
| Dec 2024 | -$40.56M(+29.1%) | -$25.66M(+109.8%) | -$40.56M(+44.3%) |
| Sep 2024 | - | -$12.23M(-320.9%) | -$28.11M(-141.4%) |
| Jun 2024 | - | $5.54M(-167.5%) | $67.82M(+234.4%) |
| Mar 2024 | - | -$8.21M(-37.9%) | $20.28M(-164.6%) |
| Dec 2023 | -$31.41M(-82.2%) | -$13.21M(-115.8%) | -$31.41M(-25.3%) |
| Sep 2023 | - | $83.70M(-299.3%) | -$42.08M(-73.7%) |
| Jun 2023 | - | -$42.01M(-29.9%) | -$160.28M(-4.2%) |
| Mar 2023 | - | -$59.90M(+150.9%) | -$167.39M(-5.0%) |
| Dec 2022 | -$176.18M(-40.5%) | -$23.87M(-30.8%) | -$176.18M(-26.4%) |
| Sep 2022 | - | -$34.50M(-29.8%) | -$239.30M(-12.0%) |
| Jun 2022 | - | -$49.12M(-28.5%) | -$272.08M(-4.0%) |
| Mar 2022 | - | -$68.70M(-21.0%) | -$283.31M(-4.3%) |
| Dec 2021 | -$296.04M(+37.8%) | -$86.99M(+29.3%) | -$296.04M(+13.3%) |
| Sep 2021 | - | -$67.28M(+11.5%) | -$261.23M(+4.3%) |
| Jun 2021 | - | -$60.34M(-25.9%) | -$250.57M(+7.0%) |
| Mar 2021 | - | -$81.42M(+56.0%) | -$234.10M(+9.0%) |
| Dec 2020 | -$214.86M(+61.6%) | -$52.18M(-7.8%) | -$214.86M(+11.3%) |
| Sep 2020 | - | -$56.62M(+29.0%) | -$193.11M(+13.8%) |
| Jun 2020 | - | -$43.88M(-29.4%) | -$169.76M(+4.9%) |
| Mar 2020 | - | -$62.18M(+104.4%) | -$161.75M(+21.7%) |
| Dec 2019 | -$132.94M(+3.0%) | -$30.43M(-8.5%) | -$132.94M(-2.4%) |
| Sep 2019 | - | -$33.27M(-7.3%) | -$136.21M(+0.2%) |
| Jun 2019 | - | -$35.88M(+7.5%) | -$135.97M(+1.2%) |
| Mar 2019 | - | -$33.37M(-1.0%) | -$134.31M(+4.1%) |
| Dec 2018 | -$129.01M(+37.6%) | -$33.70M(+2.0%) | -$129.01M(+10.1%) |
| Sep 2018 | - | -$33.03M(-3.5%) | -$117.17M(+9.6%) |
| Jun 2018 | - | -$34.22M(+21.9%) | -$106.91M(+7.4%) |
| Mar 2018 | - | -$28.07M(+28.4%) | -$99.53M(+6.1%) |
| Dec 2017 | -$93.76M(+51.4%) | -$21.85M(-4.0%) | -$93.76M(+5.4%) |
| Sep 2017 | - | -$22.78M(-15.1%) | -$88.95M(+9.5%) |
| Jun 2017 | - | -$26.83M(+20.3%) | -$81.23M(+20.7%) |
| Mar 2017 | - | -$22.30M(+30.8%) | -$67.28M(+8.6%) |
| Dec 2016 | -$61.93M(+38.4%) | -$17.05M(+13.2%) | -$61.93M(+7.2%) |
| Sep 2016 | - | -$15.05M(+16.9%) | -$57.77M(+8.2%) |
| Jun 2016 | - | -$12.88M(-24.0%) | -$53.41M(+1.2%) |
| Mar 2016 | - | -$16.95M(+31.6%) | -$52.79M(+18.0%) |
| Dec 2015 | -$44.73M(+27.5%) | -$12.88M(+20.4%) | -$44.73M(-4.8%) |
| Sep 2015 | - | -$10.70M(-12.8%) | -$46.97M(+6.0%) |
| Jun 2015 | - | -$12.26M(+37.9%) | -$44.32M(+24.4%) |
| Mar 2015 | - | -$8.89M(-41.2%) | -$35.64M(+1.6%) |
| Dec 2014 | -$35.08M(+226.5%) | -$15.12M(+87.8%) | -$35.08M(+41.1%) |
| Sep 2014 | - | -$8.05M(+125.4%) | -$24.87M(+38.4%) |
| Jun 2014 | - | -$3.57M(-57.1%) | -$17.97M(+6.0%) |
| Mar 2014 | - | -$8.33M(+69.6%) | -$16.96M(+56.6%) |
| Dec 2013 | -$10.74M(+107.1%) | -$4.91M(+325.0%) | -$10.83M(+60.4%) |
| Sep 2013 | - | -$1.16M(-54.8%) | -$6.75M(-21.4%) |
| Jun 2013 | - | -$2.56M(+16.0%) | -$8.59M(+31.5%) |
| Mar 2013 | - | -$2.20M(+164.6%) | -$6.53M(+25.9%) |
| Dec 2012 | -$5.19M(+5892.4%) | -$833.30K(-72.2%) | -$5.19M(+21.4%) |
| Sep 2012 | - | -$2.99M(+497.2%) | -$4.28M(+173.6%) |
| Jun 2012 | - | -$501.20K(-41.8%) | -$1.56M(+34.7%) |
| Mar 2012 | - | -$861.60K(-1179.7%) | -$1.16M(+1240.4%) |
| Dec 2011 | -$86.60K | $79.80K(-128.5%) | -$86.60K(-87.8%) |
| Sep 2011 | - | -$280.20K(+183.6%) | -$708.10K(-15.8%) |
| Jun 2011 | - | -$98.80K(-146.5%) | -$840.60K(-27.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $212.60K(-139.2%) | -$1.16M(-41.4%) |
| Dec 2010 | -$1.97M(+87.9%) | -$541.70K(+31.3%) | -$1.97M(+12.2%) |
| Sep 2010 | - | -$412.70K(-0.2%) | -$1.76M(+18.3%) |
| Jun 2010 | - | -$413.60K(-31.6%) | -$1.49M(+47.4%) |
| Mar 2010 | - | -$604.80K(+84.9%) | -$1.01M(-3.9%) |
| Dec 2009 | -$1.05M(-76.4%) | -$327.10K(+132.2%) | -$1.05M(-36.1%) |
| Sep 2009 | - | -$140.90K(-319.8%) | -$1.64M(-22.6%) |
| Jun 2009 | - | $64.10K(-109.9%) | -$2.12M(-41.7%) |
| Mar 2009 | - | -$645.80K(-29.8%) | -$3.64M(-18.3%) |
| Dec 2008 | -$4.45M(-56.5%) | -$919.80K(+48.3%) | -$4.45M(-9.4%) |
| Sep 2008 | - | -$620.30K(-57.3%) | -$4.92M(-30.3%) |
| Jun 2008 | - | -$1.45M(-0.7%) | -$7.05M(-25.9%) |
| Mar 2008 | - | -$1.46M(+5.7%) | -$9.51M(-7.1%) |
| Dec 2007 | -$10.24M(+31.5%) | -$1.38M(-49.8%) | -$10.24M(-0.1%) |
| Sep 2007 | - | -$2.76M(-29.6%) | -$10.25M(+6.5%) |
| Jun 2007 | - | -$3.91M(+78.9%) | -$9.62M(+17.5%) |
| Mar 2007 | - | -$2.19M(+57.4%) | -$8.19M(+5.2%) |
| Dec 2006 | -$7.79M(+23.9%) | -$1.39M(-34.8%) | -$7.79M(-8.1%) |
| Sep 2006 | - | -$2.13M(-14.1%) | -$8.48M(+9.1%) |
| Jun 2006 | - | -$2.48M(+39.1%) | -$7.77M(+14.8%) |
| Mar 2006 | - | -$1.78M(-14.2%) | -$6.77M(+7.7%) |
| Dec 2005 | -$6.28M(+7.8%) | -$2.08M(+45.8%) | -$6.28M(+1.2%) |
| Sep 2005 | - | -$1.43M(-3.7%) | -$6.21M(-0.4%) |
| Jun 2005 | - | -$1.48M(+14.1%) | -$6.23M(+7.2%) |
| Mar 2005 | - | -$1.30M(-35.1%) | -$5.81M(-0.3%) |
| Dec 2004 | -$5.83M(+68.6%) | -$2.00M(+38.3%) | -$5.83M(+5.2%) |
| Sep 2004 | - | -$1.45M(+36.1%) | -$5.54M(+20.0%) |
| Jun 2004 | - | -$1.06M(-19.0%) | -$4.62M(+9.4%) |
| Mar 2004 | - | -$1.31M(-23.4%) | -$4.22M(+22.1%) |
| Dec 2003 | -$3.46M(+351.6%) | -$1.72M(+226.9%) | -$3.46M(+72.7%) |
| Sep 2003 | - | -$524.70K(-21.5%) | -$2.00M(+29.4%) |
| Jun 2003 | - | -$668.70K(+21.7%) | -$1.55M(+13.1%) |
| Mar 2003 | - | -$549.40K(+111.6%) | -$1.37M(-4.9%) |
| Dec 2002 | -$765.70K(-83.3%) | -$259.60K(+275.1%) | -$1.44M(-26.9%) |
| Sep 2002 | - | -$69.20K(-85.9%) | -$1.97M(-20.9%) |
| Jun 2002 | - | -$489.50K(-21.0%) | -$2.49M(-9.1%) |
| Mar 2002 | - | -$619.70K(-21.4%) | -$2.74M(-40.3%) |
| Dec 2001 | -$4.58M(+246.0%) | -$788.80K(+33.8%) | -$4.58M(+97.6%) |
| Sep 2001 | - | -$589.40K(-20.4%) | -$2.32M(-5.4%) |
| Jun 2001 | - | -$740.00K(-70.0%) | -$2.45M(-27.1%) |
| Mar 2001 | - | -$2.46M(-267.1%) | -$3.36M(+153.6%) |
| Dec 2000 | -$1.32M(-44.8%) | $1.48M(-304.6%) | -$1.32M(-56.2%) |
| Sep 2000 | - | -$720.90K(-56.3%) | -$3.03M(+10.7%) |
| Jun 2000 | - | -$1.65M(+283.7%) | -$2.73M(+39.1%) |
| Mar 2000 | - | -$429.70K(+89.1%) | -$1.97M(-17.0%) |
| Dec 1999 | -$2.40M(-14.3%) | -$227.20K(-46.8%) | -$2.37M(-29.5%) |
| Sep 1999 | - | -$427.40K(-51.5%) | -$3.36M(-20.9%) |
| Jun 1999 | - | -$880.70K(+5.8%) | -$4.25M(+107.2%) |
| Mar 1999 | - | -$832.80K(-31.6%) | -$2.05M(-25.9%) |
| Dec 1998 | -$2.80M(-34.9%) | -$1.22M(-7.4%) | -$2.77M(+0.6%) |
| Sep 1998 | - | -$1.31M(-199.9%) | -$2.75M(+4.3%) |
| Jun 1998 | - | $1.32M(-184.9%) | -$2.63M(-47.8%) |
| Mar 1998 | - | -$1.55M(+29.1%) | -$5.05M(+17.4%) |
| Dec 1997 | -$4.30M(+4.9%) | -$1.20M(0.0%) | -$4.30M(+38.7%) |
| Sep 1997 | - | -$1.20M(+9.1%) | -$3.10M(+63.2%) |
| Jun 1997 | - | -$1.10M(+37.5%) | -$1.90M(+137.5%) |
| Mar 1997 | - | -$800.00K | -$800.00K |
| Dec 1996 | -$4.10M | - | - |
FAQ
- What is TG Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual FCF year-on-year change?
- What is TG Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly FCF year-on-year change?
- What is TG Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. TTM FCF year-on-year change?
What is TG Therapeutics, Inc. annual free cash flow?
The current annual FCF of TGTX is -$40.56M
What is the all time high annual FCF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual free cash flow is -$86.60K
What is TG Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, TGTX annual free cash flow has changed by -$9.15M (-29.12%)
What is TG Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of TGTX is $7.39M
What is the all time high quarterly FCF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly free cash flow is $83.70M
What is TG Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, TGTX quarterly free cash flow has changed by +$1.86M (+33.56%)
What is TG Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of TGTX is -$59.24M
What is the all time high TTM FCF for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high TTM free cash flow is $67.82M
What is TG Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, TGTX TTM free cash flow has changed by -$127.06M (-187.34%)